FDC advances on clearing USFDA GMP inspection at Roha facility

07 May 2018 Evaluate

FDC is currently trading at Rs. 259.00, up by 4.00 points or 1.57% from its previous closing of Rs. 255.00 on the BSE.

The scrip opened at Rs. 259.00 and has touched a high and low of Rs. 259.00 and Rs. 259.00 respectively.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 319.00 on 07-Mar-2018 and a 52 week low of Rs. 164.00 on 31-Aug-2017.

Last one week high and low of the scrip stood at Rs. 259.00 and Rs. 240.00 respectively. The current market cap of the company is Rs. 4,605.00 crore.

The promoters holding in the company stood at 69.07%, while Institutions and Non-Institutions held 13.63% and 17.30% respectively.

FDC’s manufacturing facility for Active Pharmaceutical Ingredients (API’s) located at Roha in state of Maharashtra, was recently inspected by US Food and Drug Administration (USFDA). It has successfully cleared the USFDA GMP inspection with ‘No observation’.

This was the 12th consecutive successful USFDA inspection of this facility. The Active Pharmaceutical Ingredients (API’s) manufactured at the above facility continues to be exported to USA.

FDC is engaged in manufacture of specialized formulations, and oral rehydration salts (ORS).



FDC Share Price

407.45 -3.00 (-0.73%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×